1,2,3,4-Tetrahydroisoquinoline produces an antidepressant-like effect in the forced swim test and chronic mild stress model of depression in the rat: Neurochemical correlates

European Journal of Pharmacology

Volumn 729, Issue 1, 2014, Pages 107-115

  Mozdzeń, Edyta ^a   Papp, Mariusz ^a   Gruca, Piotr ^a   Wa̧sik, Agnieszka ^a   Romańska, Irena ^a   Michaluk, Jerzy ^a   Antkiewicz Michaluk, Lucyna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1,2,3,4 Tetrahydroisoquinoline; Chronic mild stress; Forced swimming test; Imipramine; Metabolism of monoamines; Models of depression; Rat brain

Indexed keywords

3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; IMIPRAMINE; NORADRENALIN; TETRAHYDROISOQUINOLINE; ANTIDEPRESSANT AGENT; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CHRONIC STRESS; CLIMBING; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FORCED SWIM TEST; IMMOBILITY; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SUBSTANTIA NIGRA; ANIMAL; BRAIN LEVEL; DISEASE MODEL; DRUG EFFECTS; DRUG THERAPY; MENTAL STRESS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; PSYCHOLOGY; SWIMMING; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN CHEMISTRY; DEPRESSION; DISEASE MODELS, ANIMAL; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; SWIMMING; TETRAHYDROISOQUINOLINES; TREATMENT OUTCOME;

EID: 84895168057     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.01.075     Document Type: Article

References (44)

1. J.C. Alvarez, M. Sanceaume, C. Advenier, and O. Spreux-Varoquaux Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice Eur. Neuropsychopharmacol. 10 1999 31 36
2. L. Antkiewicz-Michaluk, I. Romańska, I. Papla, J. Michaluk, M. Bakalarz, J. Vetulani, A. Krygowska-Wajs, and A. Szczudlik Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain Neuroscience 96 2000 59 64 (Pubitemid 30103603)
3. L. Antkiewicz-Michaluk, J. Michaluk, M. Mokrosz, I. Romańska, E. Lorenc-Koci, S. Otha, and J. Vetulani Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties J. Neurochem. 78 2001 100 108 (Pubitemid 32622592)
4. L. Antkiewicz-Michaluk, J.W. Łazarewicz, A. Patsenka, M. Kajta, E. Ziemińska, E. Salińska, A. Wa̧sik, K. Gołembiowska, and J. Vetulani The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity J. Neurochem. 97 2006 846 856
5. F. Borsini Role of the serotonergic system in the forced swimming test Neurosci. Biobehav. Rev. 19 1995 377 395
6. F. Borsini, and A. Meli Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94 1988 147 160 (Pubitemid 18040687)
7. J.F. Cryan, M.E. Page, and I. Lucki Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment Psychopharmacology 182 2005 335 344 (Pubitemid 41464645)
8. M.J. Detke, M. Rickels, and I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotoninergic and noradrenergic antidepressants Psychopharmacology (Berlin) 121 1995 66 72
9. G.L. Grunewald, T.J. Reitz, J.A. Ruth, S. Vollmer, L.E. Eiden, and C.O. Ruthedge Inhibition of neuronal uptake of 3H-biogenic amines rat cerebral cortex by partially and fully saturated derivatives of imipramine and desipramine. The importance of the aromatic ring in adrenergic amines - Part 3 Biochem. Pharmacol. 28 1979 417 421
10. W. Haefely, W.P. Burkard, A.M. Cesura, R. Kettler, H.P. Lorez, J.R. Martin, J.G. Richards, R. Scherschlicht, and M. Da Prada Biochemistry and pharmacology of moclobemide, a prototype RIMA Psychopharmacology (Berlin) 106 1992 6 14
11. J.I. Javaid, J.M. Perel, and J.M. Davis Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain Life Sci. 24 1979 21 28 (Pubitemid 9107782)
12. K. Kasamo, P. Blier, and C. De Montigny Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain Neurobiol. Psych., Canada 277 1996 278 286 (Pubitemid 27169071)
13. Y. Kitamura, K. Kitagawa, S. Kimoto, H. Sagara, K. Shibata, H. Kawasaki, T. Sendo, and Y. Gomita Selegilin exerts antidepressant-like effects during the forced swim test in adrenocorticotropic hormone-treated rats J. Pharmacol. Sci. 106 2008 639 644 (Pubitemid 351556243)
14. J. Kodydkova, L. Vavrova, M. Zeman, R. Jirak, J. Macasek, B. Stankova, E. Tvrzicka, and A. Zak Antioxidative enzymes and increased oxidative stress in depressive women Clin. Biochem. 42 2009 1368 1374
15. M. Kohno, S. Otha, and M. Hirobe Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain Biochem. Biophys. Res. Commun. 140 1986 448 454 (Pubitemid 17190044)
16. Y. Kumagae, Y. Matsui, and N. Iwata Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359 Jpn. J. Pharmacol. 55 1991 121 128
17. J.W.M. Lenders, G. Eisenhofer, N.G.G.M. Abeling, W. Berger, D.L. Murphy, H. Konings, L.M. Bleeker Wagemakers, I.J. Kopin, F. Karoum, A.H. Van Gennip, and H.G. Brunner Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes J. Clin. Invest. 97 1996 1010 1019 (Pubitemid 26070581)
18. E. Lorenc-Koci, M. Śmiałowska, L. Antkiewicz-Michaluk, K. Gołembiowska, M. Bajkowska, and S. Wolfarth Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats Neuroscience 95 2000 1049 1059 (Pubitemid 30006893)
19. E. Lorenc-Koci, M. Sokołowska, I. Kwiecień, and L. Włodek Treatment with 1,2,3,4-tetrahydroisoquinoline affects the levels of nitric oxide, S-nitrosothiols, glutathione and the enzymatic activity of gamma-glutamyl transpeptidase in the dopaminergic structures of rat brain Brain Res. 1049 2005 133 146 (Pubitemid 41072929)
20. M. Maes The cytokine hypothesis of depression: inflammation, oxidative and nitrosative stress and leaky gut as a new target for adjunctive treatments in depression Neuro. Endocrinol. Lett. 29 2008 287 291
21. M. Maes, P. Galecki, Y.S. Chang, and M. Berk A review on the oxidative and nitrosative stress pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness Prog. Neuro-Psychopharmacol. Biol. Psychiatry 35 2011 676 692
22. M. Maes, J. Mylle, L. Delmeire, and C. Altamura Psychiatric morbidity and comorbidity following accidental man-made traumatic events: incidence and risk factors Eur. Arch. Psychiatry Clin. Neurosci. 250 2000 156 162 (Pubitemid 30417216)
23. M. Mahmoudi, M.A. Ebrahimzadeh, F. Ansaroudi, S.F. Nabavi, and S.M. Nabovi Antidepressant and antioxidant activities of Artemisia absinthium L. at flowering stage Afr. J. Biotech. 8 2009 7170 7175
24. Y. Makino, S. Ohta, O. Tachikawa, and M. Hirobe Presence of tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline in foods: compounds related to Parkinson×s disease Life Sci. 43 1988 373 378
25. W. Maruyama, D. Nakahara, P. Dostert, and A. Takahashi Naturally-occurring isoquinolines perturb monoamine metabolism in the brain: studied by in vivo microdialysis J. Neural. Transm. Gen. Sect. 94 1993 91 102 (Pubitemid 23345518)
26. J. Michaluk, A. Krygowska-Wajs, B. Karolewicz, and L. Antkiewicz-Michaluk Role of noradrenergic system In the mechanism of action of endogenous neurotoxin 1,2,3,4-tetrahydroisoquinoline: biochemical and functional studies Pol. J. Pharmacol. 54 2002 19 25 (Pubitemid 34269619)
27. H. Miura, M. Naoi, D. Nakahara, T. Ohta, and T. Nagatsu Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice Pharmacol. Biochem. Behav. 53 1996 469 475 (Pubitemid 26059209)
28. F. Murray, D.W. Smith, and P.H. Huston Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviors in mice Eur. J. Pharmacol. 583 2008 115 127
29. T. Niwa, H. Yoshizumi, A. Tatematsu, and S. Matsuura Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods J. Chromatogr. 493 1989 347 352 (Pubitemid 19220073)
30. A. Patsenka, and L. Antkiewicz-Michaluk Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds - 1,2,3,4-tetrahydro-isoquinoline alkaloids Pol. J. Pharmacol. 56 2004 727 734 (Pubitemid 40287474)
31. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioural despair test in rats: a new model sensitive to antidepressant treatments Eur. J. Pharmacol. 47 1978 379 391
32. J.P. Reneric, and I. Lucki Antidepressant behavioral effects by inhibition of monoamine re-uptake in the rat forced swimming test Psychopharmacology 136 1998 190 197 (Pubitemid 28137959)
33. E. Richelson Pharmacology of antidepressants - characteristics of the ideal drug Mayo Clin. Proc. 69 1994 1069 1081 (Pubitemid 24346991)
34. J. Vetulani, and I. Nalepa Antidepressants: past, present and future Eur. J. Pharmacol. 405 2000 351 363
35. A. Wa̧sik, E. Mozdzeń, I. Romańska, J. Michaluk, and L. Antkiewicz-Michaluk Antidepressant-like activity of the endogenous amine, 1-methyl-1,2,3,4-tetrahydroisoquinoline in the behavioral despair test in the rat, and its neurochemical correlates: a comparison with the classical antidepressant, imipramine Eur. J. Pharmacol. 700 2013 110 117
36. P. Willner Animal model of depression: an overview Pharmacol. Ther. 45 1990 425 455
37. P. Willner Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation (Review) Psychopharmacology 134 1997 319 329 (Pubitemid 28023396)
38. P. Willner Chronic mild stress (CMS) revisited: consistency and behavioral-neurobiological concordance in the effects of CMS Neuropsychobiology 52 2005 90 110 (Pubitemid 41160326)
39. P. Willner, R. Muscat, and M. Papp Chronic mild stress-induced anhedonia: a realistic animal model of depression Neurosci. Biobehav. Rev. 16 1992 525 534
40. T. Yamakawa, Y. Kotake, M. Fujitani, H. Shintani, Y. Makino, and S. Ohta Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain Neurosci. Lett. 276 1999 68 70 (Pubitemid 29525527)
41. M.B. Youdim, and Y.S. Bakhle Monoamine oxidase: isoforms and inhibitors in Parkinson×s disease and depressive illness Brit. J. Pharmacol. 147 2006 287 296
42. M.B. Youdim, D. Edmondson, and K.F. Tipton The therapeutic potential of monoamine oxidase inhibitors Nat. Rev. Neurosci. 7 2006 295 309
43. J.Z. Zhang Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders Life Sci. 75 2004 1659 1699
44. Y. Zhao, R. Ma, J. Shen, H. Su, D. Xing, and L. Du A mouse model of depression induced by repeated corticosterone injections Eur. J. Pharmacol. 581 2008 113 120